Moderna says it will make up to 110 million doses of its COVID-19 vaccine available to African countries. Tuesday’s announcement says Moderna is prepared to deliver the first 15 million doses by the end of this year, with 35 million in the first quarter of 2022 and up to 60 million in the second quarter.
It says “all doses are offered at Moderna’s lowest tiered price.” The company called it “the first step in our long-term partnership with the African Union,” which has been outspoken about the need for many more COVID-19 vaccine doses.
Africa and its 1.3 billion people remain the least-vaccinated region of the world against COVID-19, with just over 5 per cent fully vaccinated. Moderna said this agreement is separate from its deal with the global COVAX project to supply up to 500 million doses from late this year through 2022.
COVAX aims to supply doses to low- and middle-income countries.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022